Found: 108
Select item for more details and to access through your institution.
Small Device, Big Impact! A Foray into State-of-the-Art Nanopore Sequencing Technology.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 238, doi. 10.36401/JIPO-24-X2
- By:
- Publication type:
- Article
A prolonged response to platinum‐based therapy in a patient with metastatic urothelial carcinoma harboring a single rearranged and truncated NF2 gene.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 8, p. 430, doi. 10.1002/gcc.22537
- By:
- Publication type:
- Article
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions.
- Published in:
- BJU International, 2020, v. 125, n. 5, p. 739, doi. 10.1111/bju.15006
- By:
- Publication type:
- Article
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0208097
- By:
- Publication type:
- Article
Patient-specific 3D in vitro modeling and fluid dynamic analysis of primary pulmonary vein stenosis.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2024.1432784
- By:
- Publication type:
- Article
Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 1, p. 456, doi. 10.1159/000506625
- By:
- Publication type:
- Article
A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib.
- Published in:
- Case Reports in Oncology, 2014, v. 7, n. 3, p. 628, doi. 10.1159/000367780
- By:
- Publication type:
- Article
Extended Antitumor Responseof a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib.
- Published in:
- Case Reports in Oncology, 2014, v. 7, n. 2, p. 343, doi. 10.1159/000363377
- By:
- Publication type:
- Article
Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary.
- Published in:
- Case Reports in Oncology, 2014, v. 7, n. 2, p. 503, doi. 10.1159/000365326
- By:
- Publication type:
- Article
Hemodynamic and analgesic effect of intrathecal fentanyl with bupivacaine in patients undergoing elective cesarean section; a prospective cohort study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0268318
- By:
- Publication type:
- Article
Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 130, n. 1, p. 211, doi. 10.1007/s11060-016-2237-3
- By:
- Publication type:
- Article
Machining Characteristics of Stir-Cast Al-TiB<sub>2</sub> Composites in Dry Turning.
- Published in:
- International Journal of Metalcasting, 2024, v. 18, n. 1, p. 835, doi. 10.1007/s40962-023-01091-w
- By:
- Publication type:
- Article
Comprehensive genomic profiling of malignant phyllodes tumors of the breast.
- Published in:
- 2017
- By:
- Publication type:
- Report
Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study.
- Published in:
- 2016
- By:
- Publication type:
- Report
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 154, n. 1, p. 155, doi. 10.1007/s10549-015-3592-z
- By:
- Publication type:
- Article
Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNA.
- Published in:
- Oncology, 2020, v. 98, n. 12, p. 905, doi. 10.1159/000510241
- By:
- Publication type:
- Article
A Pan-Cancer Landscape Analysis Reveals a Subset of Endometrial Stromal and Pediatric Tumors Defined by Internal Tandem Duplications of BCOR.
- Published in:
- Oncology, 2019, v. 96, n. 2, p. 101, doi. 10.1159/000493322
- By:
- Publication type:
- Article
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.
- Published in:
- Oncology, 2016, v. 91, n. 6, p. 348, doi. 10.1159/000449204
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma.
- Published in:
- Oncology, 2016, v. 90, n. 6, p. 339, doi. 10.1159/000445978
- By:
- Publication type:
- Article
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib.
- Published in:
- 2016
- By:
- Publication type:
- case study
RET rearrangements are actionable alterations in breast cancer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07341-4
- By:
- Publication type:
- Article
Recurrent secondary genomic alterations in desmoplastic small round cell tumors.
- Published in:
- BMC Medical Genetics, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s12881-020-01034-w
- By:
- Publication type:
- Article
Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. e82, doi. 10.1093/oncolo/oyac180
- By:
- Publication type:
- Article
Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e715, doi. 10.1002/onco.13694
- By:
- Publication type:
- Article
Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e78, doi. 10.1634/theoncologist.2020-0509
- By:
- Publication type:
- Article
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e147, doi. 10.1634/theoncologist.2019-0244
- By:
- Publication type:
- Article
Pan‐Cancer Analysis of CDK12 Loss‐of‐Function Alterations and Their Association with the Focal Tandem‐Duplicator Phenotype.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1526, doi. 10.1634/theoncologist.2019-0214
- By:
- Publication type:
- Article
FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1462, doi. 10.1634/theoncologist.2019-0121
- By:
- Publication type:
- Article
MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1305, doi. 10.1634/theoncologist.2019-0230
- By:
- Publication type:
- Article
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1340, doi. 10.1634/theoncologist.2019-0034
- By:
- Publication type:
- Article
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 791, doi. 10.1634/theoncologist.2018-0334
- By:
- Publication type:
- Article
Hybrid Capture‐Based Genomic Profiling Identifies BRAF V600 and Non‐V600 Alterations in Melanoma Samples Negative by Prior Testing.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 657, doi. 10.1634/theoncologist.2018-0271
- By:
- Publication type:
- Article
Genomic Features for Therapeutic Insights of Chemotherapy‐Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. e142, doi. 10.1634/theoncologist.2018-0430
- By:
- Publication type:
- Article
Hybrid Capture‐Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well‐Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing.
- Published in:
- Oncologist, 2018, v. 23, n. 7, p. 776, doi. 10.1634/theoncologist.2017-0493
- By:
- Publication type:
- Article
Tumor Mutational Burden Guides Therapy in a Treatment Refractory <italic>POLE‐</italic>Mutant Uterine Carcinosarcoma.
- Published in:
- Oncologist, 2018, v. 23, n. 5, p. 518, doi. 10.1634/theoncologist.2017-0342
- By:
- Publication type:
- Article
ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.
- Published in:
- Oncologist, 2017, v. 22, n. 12, p. 1444, doi. 10.1634/theoncologist.2016-0488
- By:
- Publication type:
- Article
A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 768, doi. 10.1634/theoncologist.2017-0054
- By:
- Publication type:
- Article
Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture-Based Assay of Circulating Tumor DNA.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 774, doi. 10.1634/theoncologist.2016-0376
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 834, doi. 10.1634/theoncologist.2016-0287
- By:
- Publication type:
- Article
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 416, doi. 10.1634/theoncologist.2016-0310
- By:
- Publication type:
- Article
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
- Published in:
- Oncologist, 2017, v. 22, n. 3, p. 255, doi. 10.1634/theoncologist.2016-0279
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers.
- Published in:
- Oncologist, 2017, v. 22, n. 2, p. 152, doi. 10.1634/theoncologist.2015-0511
- By:
- Publication type:
- Article
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 11, p. 1306, doi. 10.1634/theoncologist.2016-0148
- By:
- Publication type:
- Article
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
- Published in:
- Oncologist, 2016, v. 21, n. 11, p. 1315, doi. 10.1634/theoncologist.2016-0049
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 684, doi. 10.1634/theoncologist.2016-0030
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-ResponsiveALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 762, doi. 10.1634/theoncologist.2015-0497
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 33, doi. 10.1634/theoncologist.2015-0241
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1132, doi. 10.1634/theoncologist.2015-0156
- By:
- Publication type:
- Article